Neal Rosen

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sloan-Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Other. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neal Rosen. Retrieved from https://idiyas.com/inventor/neal-rosen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 174(Granted Patents)

Location History:

Englewood, NJ (US) (2002 - 2016)
New York, NY (US) (2007 - 2022)

Company Filing History:

10 out of 519

Sloan-Kettering Institute for Cancer Research

patents

4 out of 618

Memorial Sloan Kettering Cancer Center

patents

1 out of 834,453

Other

patents

Years Active: 2002-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11458139 - Use of BRAF inhibitors for treating cutaneous reactions caused by treatment with a MEK inhibitor (2022-10-04),

2. 10792284 - Synergistic cancer treatment (2020-10-06),

3. 9481910 - Methods and compositions for the detection of drug resistant BRAF isoforms (2016-11-01),

4. 8518897 - Method of treatment for cancers associated with elevated HER2 levels (2013-08-27),

5. 7825094 - Method of treatment for cancers associated with elevated HER 2 levels (2010-11-02),

6. 7812143 - Biomarkers for cancer treatment (2010-10-12),

7. 7439359 - Small molecule compositions for binding to hsp90 (2008-10-21),

8. 7271160 - Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases (2007-09-18),

9. 7238682 - Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases (2007-07-03),

10. 7211562 - Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors (2007-05-01),

11. 7115651 - Macrocycles and uses thereof (2006-10-03),

12. 6989383 - Method of treating cancer (2006-01-24),

13. 6946456 - Methods for treating cell proliferative disorders and viral infections (2005-09-20),

14. 6670348 - Methods and compositions for destruction of selected proteins (2003-12-30),

15. 6482851 - Synthesis of dysidiolide and uses thereof (2002-11-19),

Title: Inventor Neal Rosen - Revolutionizing Technology in Englewood

Introduction: Neal Rosen is a visionary inventor based in Englewood, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Neal Rosen holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Neal Rosen has consistently pushed the boundaries of technological advancement, leading to the development of innovative solutions that have revolutionized various industries.

Collaborations: Throughout his career, Neal Rosen has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life, fostering a culture of innovation and creativity in the process.

Conclusion: Neal Rosen's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

Profile summary based on public USPTO records.